NKG2A + CD8 + T cells infiltration determines immunosuppressive contexture and inferior response to immunotherapy in clear cell renal cell carcinoma

Youqi Qiu,Li Liu,Wenbin Jiang,Ziyang Xu,Jiahao Wang,Siyuan Dai,Jianming Guo,Jiejie Xu
DOI: https://doi.org/10.1136/jitc-2023-008368
IF: 12.469
2024-01-01
Journal for ImmunoTherapy of Cancer
Abstract:Background Immunotherapy is gaining momentum, but current treatments have limitations in terms of beneficiaries. Clear cell renal cell carcinoma (ccRCC) harbors the highest expression of human leukocyte antigen E (HLA-E), ligand of NKG2A, among all solid tumors. In this study, we aim to investigate the role of NKG2A + CD8 + T cells in tumor microenvironment and its potential as a novel target in ccRCC. Methods This study included four independent cohorts, including 234 patients from Zhongshan cohort (ZSHC) who underwent partial or radical nephrectomy at Zhongshan Hospital, and 117 metastatic patients from metastatic Zhongshan cohort (ZSHC-metastatic renal cell carcinoma) who were treated with immune checkpoint inhibitor or tyrosine kinase inhibitor alone. We also incorporated a cohort of 530 patients diagnosed with ccRCC from The Cancer Genome Atlas (referred to as TCGA-kidney renal clear cell carcinoma) and 311 patients from CheckMate cohort for bioinformatics exploration and hypothesis validation. Fresh surgical specimens from 15 patients who underwent ccRCC surgery at Zhongshan Hospital were collected for flow cytometry analysis. Another 10 fresh surgical specimens were used to investigate the therapeutic potential of NKG2A blockade after in vitro intervention. The infiltration of NKG2A + CD8 + T cells was assessed using immunohistochemical staining, flow cytometry, and immunofluorescence staining in ZSHC cohort. Results Patients with higher infiltration of NKG2A + CD8 + T cells in ccRCC exhibited shorter overall survival and resistance to immunotherapy. NKG2A + CD8 + T cells expressed upregulated checkpoint molecules and displayed impaired effector functions, along with tissue-residency characteristics. Combination of programmed cell death protein-1 (PD-1) blockade and NKG2A blockade demonstrated an enhanced capability in reactivating CD8 + T cells effector functions. Conclusion Intense infiltration of NKG2A + CD8 + T cells were associated with poorer prognosis and response to immunotherapy. NKG2A blockade combined with current immunotherapy exhibited a robust ability to reactivate CD8 + T cells effector functions.
oncology,immunology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: the role of NKG2A+CD8+ T cells in the tumor microenvironment of clear cell renal cell carcinoma (ccRCC) and their potential as new therapeutic targets. Specifically, the research aims to explore the following aspects: 1. **The relationship between the infiltration of NKG2A+CD8+ T cells and the immunosuppressive microenvironment**: - The study found that NKG2A+CD8+ T cells show a higher level of infiltration in ccRCC, and these cells express up - regulated checkpoint molecules (such as PD - 1, LAG - 3, etc.), indicating impaired function and tissue - resident characteristics. - The presence of NKG2A+CD8+ T cells is associated with an immunosuppressive microenvironment, including enriched regulatory CD4+ T cells (Tregs). 2. **The impact of NKG2A+CD8+ T cells on the response to immunotherapy**: - High infiltration of NKG2A+CD8+ T cells in patients is associated with a poorer prognosis and resistance to immunotherapy. - Combining programmed death - 1 (PD - 1) blockade and NKG2A blockade can significantly enhance the re - activation of CD8+ T - cell effector functions, thereby improving the efficacy of immunotherapy. 3. **The clinical significance of NKG2A+CD8+ T cells**: - The study verified the relationship between high infiltration of NKG2A+CD8+ T cells and shortened patient survival and increased recurrence risk through data analysis of multiple independent cohorts. - Multivariate analysis shows that NKG2A+CD8+ T - cell infiltration is an independent predictor affecting overall survival. In summary, this study reveals the important role of NKG2A+CD8+ T cells in ccRCC, providing a theoretical basis for the development of new immunotherapy strategies, especially the possibility of combining NKG2A blockade with existing immunotherapy methods.